However, it has been discovered that Ephrin-B1 interacts with IL2 to inhibit AtIRT1 transport activity, and the mechanism is very similar to that we found that ZIP4 binds Ephrin-B1 to inhibit its ubiquitination and thereby promote EMT in HCC. Here, IL2 is linked to hepatocellular carcinoma.